πŸ›οΈ Verified NIH Record β€’ Updated 2026-04-09

Detecting Changes in Arterial Blood Volume and Cardiac Efficiency (NCT07205341)

A Pilot Clinical Study to Assess Correlation Between Arterial Blood Volume Status and Cardiac Efficiency, and HemoCept Device Data in Trans-Aortic Valve Replacement (TAVR} Surgery

🟒 Recruiting Interventional Protocol πŸ“Š Observational Clinical Research Sponsor: HemoCept Inc.

🩺 Plain-English Summary (8th-Grade Level)

The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.

Who can join: Review the eligibility criteria below.

Location: Boulder Heart β€” Boulder, Colorado

Age range: 18 Years to 80 Years

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (1 Sites)

  • Boulder Heart β€” Boulder, Colorado

πŸ“ž Contact the Study Coordinator

Phone: (303) 442-2395

Email: kathari.adkins@bch.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—